MedPath

Mast cell activation syndrome - recognising patterns and triggers

Conditions
IDIOPATHISCHENMASTZELLAKTIVIERUNGSSYNDROM
Registration Number
DRKS00025475
Lead Sponsor
Klinik fu¨r Dermatologie, Venerologie und AllergologieCharité - Universitätsmedizin Berlin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
934
Inclusion Criteria

Adult (= 18 years) persons with suspected iMCAS can participate in the study. The ability to give informed consent is required.

Exclusion Criteria

Children and adolescents < 18 years

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Characterisation of patients with a suspected diagnosis of iMCAS.<br>- Categorisation of these patients according to various characteristics (e.g. iMCAS symptoms).
Secondary Outcome Measures
NameTimeMethod
- Comparison of patient categories according to further characteristics (e.g. age, gender, symptom constellation, risk factors, concomitant diseases, duration of disease, quality of life, living environment, social history, etc.).
© Copyright 2025. All Rights Reserved by MedPath